1, 4‐Dihydropyridine Ca2+ channel antagonists and activators: A comparison of binding characteristics with pharmacology (original) (raw)
1,4-dihydropyridine calcium channel ligands: Selectivity of action. The roles of pharmacokinetics, state-dependent interactions, channel isoforms, and other factors
David Triggle
Drug Development Research, 2003
View PDFchevron_right
Analysis of the properties of binding of calcium-channel activators and inhibitors to dihydropyridine receptors in chick heart membranes
ATTQA MAAN
Circulation research, 1987
View PDFchevron_right
Selectivity of dihydropyridines for cardiac L-type and sympathetic N-type Ca2+ channels
Hisayuki Uneyama
European Journal of Pharmacology, 1999
View PDFchevron_right
Pharmacologic and radioligand binding analysis of the actions of 1,4-dihydropyridine activators related to Bay K 8644 in smooth muscle, cardiac muscle and neuronal preparations
David Triggle
Naunyn-Schmiedeberg's Archives of Pharmacology, 2004
View PDFchevron_right
Activation of the voltage-dependent Ca2+ channel in rat heart cells by dihydropyridine derivatives
Michel Lazdunski
Biochemical and Biophysical Research Communications, 1984
View PDFchevron_right
Calcium Channels in the Heart : Properties and Modulation by Dihydropyridine Enantiomers
Hartmut Porzig
1988
View PDFchevron_right
The interactions of 1,4-dihydropyridines bearing a 2-(2-aminoethylthio)methyl substituent at voltage-dependent Ca + channels of smooth muscle, cardiac muscle and neuronal tissues
David Triggle
Naunyn-schmiedebergs Archives of Pharmacology, 1990
View PDFchevron_right
The interactions of 1,4-dihydropyridines bearing a 2-(2-aminoethylthio)methyl substituent at voltage-dependent Ca 2 + channels of smooth muscle, cardiac muscle and neuronal tissues
David Triggle
Naunyn Schmied Arch Pharmacol, 1990
View PDFchevron_right
Ca2+Channel inhibition by a new dihydropyridine derivatives,S111568 and its enantiomers S12967 and S12968
Hervé Aptel
European Journal of Pharmacology, 1990
View PDFchevron_right
Binding sites for 1,4-dihydropyridine Ca2+-channel modulators in rat intestinal smooth muscle
Salvatore Salomone
Naunyn-Schmiedeberg's Archives of Pharmacology, 1991
View PDFchevron_right
1,4-Dihydropyridine antagonist activities at the calcium channel: a quantitative structure-activity relationship approach
David Triggle
Journal of Medicinal Chemistry, 1988
View PDFchevron_right
1,4-Dihydropyridines as calcium channel ligands and privileged structures
David Triggle
Cellular and molecular neurobiology, 2003
View PDFchevron_right
Purification of the dihydropyridine receptor of the voltage-dependent Ca2+ channel from skeletal muscle transverse tubules using (+) [3H]PN 200-110
Michel Lazdunski
Biochemical and Biophysical Research Communications, 1984
View PDFchevron_right
A novel dihydropyridine with 3-aryl meta-hydroxyl substitution blocks L-type calcium channels in rat cardiomyocytes
Pedro Ibarra ayala
Toxicology and applied pharmacology, 2014
View PDFchevron_right
Inhibition of cardiac L-type calcium channels by quaternary amlodipine: implications for pharmacokinetics and access to dihydropyridine binding site
Jorge Capdevila
Journal of Molecular and Cellular Cardiology, 1995
View PDFchevron_right
(+)-S-12967 and (-)-S-12968: 1,4-dihydropyridine stereoisomers with calcium channel agonistic and antagonistic properties in rat resistance arteries
Dolores Prieto
British Journal of Pharmacology, 1991
View PDFchevron_right
Potentiation of the Cardiac L-Type Ca2+ Channel (alpha1C) by Dihydropyridine Agonist and Strong Depolarization Occur via Distinct Mechanisms
M. Grabner
The Journal of General Physiology, 2001
View PDFchevron_right
Cardiac electrophysiological effects of a new dihydrophyridine calcium antagonist (BBR 2160)
I. Masini
Pharmacological Research, 1991
View PDFchevron_right
Ca2+ channel blocking activity of lacidipine and amlodipine in A7r5 vascular smooth muscle cells
Emiliangelo Ratti
European Journal of Pharmacology: Molecular Pharmacology, 1993
View PDFchevron_right
Dihydropyridine-sensitive Ca2+channel in aneurally cultured human muscles Relationship between high-affinity binding site and inhibition of calcium uptake
Valerie Askanas
FEBS Letters, 1988
View PDFchevron_right
The 1,4-Dihydropyridine Nucleus: A Pharmacophoric Template Part 1. Actions at Ion Channels
David Triggle
Mini-Reviews in Medicinal Chemistry, 2003
View PDFchevron_right
Identification of 1,4-dihydropyridine binding domains within the primary structure of the α1 subunit of the skeletal muscle L-type calcium channel
Huba Kalasz
FEBS Letters, 1993
View PDFchevron_right
Comparison of high affinity binding of calcium channel blocking drugs to vascular smooth muscle and cardiac sarcolemmal membranes
David Triggle
Biochemical Pharmacology, 1984
View PDFchevron_right
Receptors for diphenylbutylpiperidine neuroleptics in brain, cardiac, and smooth muscle membranes. Relationship with receptors for 1,4-dihydropyridines and phenylalkylamines and with Ca2+ channel blockade
jean pierre galizzi
European Journal of Pharmacology, 1987
View PDFchevron_right
Dihydropyridine-sensitive Ca2+ channels in mammalian skeletal muscle cells in culture: electrophysiological properties and interactions with Ca2+ channel activator (Bay K8644) and inhibitor (PN 200-110)
jean pierre galizzi
Proceedings of the National Academy of Sciences, 1986
View PDFchevron_right
Different potencies of dihydropyridine derivatives in blocking T-type but not L-type Ca2+ channels in neuroblastoma-glioma hybrid cells
Wolfgang Stengel
European Journal of Pharmacology, 1998
View PDFchevron_right
Antagonism of 4-substituted 1,4-dihydropyridine-3,5-dicarboxylates toward voltage-dependent L-type Ca2+ channels CaV1.3 and CaV1.2
Sara Dunne
Bioorganic & Medicinal Chemistry, 2010
View PDFchevron_right
Antagonism of L-type Ca2+ channels CaV1.3 and CaV1.2 by 1,4-dihydropyrimidines and 4H-pyrans as dihydropyridine mimics
Sara Dunne
Bioorganic & Medicinal Chemistry, 2013
View PDFchevron_right
Dihydropyridine receptors are primarily functional L-type calcium channels in rabbit ventricular myocytes
Larry Hryshko
Circulation Research, 1991
View PDFchevron_right
Molecular level model for the agonist/antagonist selectivity of the 1,4-dihydropyridine calcium channel receptor
David Triggle
Journal of Computer-Aided Molecular Design, 1991
View PDFchevron_right
Mechanism of Action of Calcium Channel Modulator Drugs
Kiyoshi Itagaki
Annals of the New York Academy of Sciences, 1988
View PDFchevron_right
Identification of the site of interaction of the dihydropyridine channel blockers nitrendipine and azidopine with the calcium-channel alpha 1 subunit
Helmut E. Meyer
The EMBO Journal, 1991
View PDFchevron_right
Interaction of Dihydropyridine Calcium Channel Agonists and Antagonists with Adenosine Receptors
Kenneth A Jacobson
Pharmacology & Toxicology, 1987
View PDFchevron_right
Toward an understanding of the dihydropyridine-sensitive calcium channel
Edward McKenna
Biochemical Pharmacology, 1990
View PDFchevron_right
The Mode of Action of Dihydropyridines in Vascular Smooth Muscle
Theophile Godfraind
Annals of the New York Academy of Sciences, 1988
View PDFchevron_right